Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

NCT01106430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: Lisdexamfetamine Dimesylate
DRUG: Atomoxetine Hydrochloride

Sponsor

Shire